These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34070592)

  • 21. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
    Kim DW; Lim SB; Kim DY; Kim TH; Jung KH; Kim DH; Chang HJ; Sohn DK; Hong CW; Choi HS; Jeong SY; Park JG
    Eur J Surg Oncol; 2006 Mar; 32(2):162-7. PubMed ID: 16289718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer.
    Partl R; Paal K; Stranz B; Hassler E; Magyar M; Brunner TB; Langsenlehner T
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer.
    Sun Z; Yu X; Wang H; Ma M; Zhao Z; Wang Q
    Exp Ther Med; 2015 Aug; 10(2):484-490. PubMed ID: 26622341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based use of sphincter-preserving surgery in patients with rectal cancer: is there room for improvement?
    Richardson DP; Porter GA; Johnson PM
    Dis Colon Rectum; 2013 Jun; 56(6):704-10. PubMed ID: 23652743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy.
    Partl R; Lukasiak K; Thurner EM; Renner W; Stranzl-Lawatsch H; Langsenlehner T
    Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33023215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
    Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
    Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphincter-preserving operations for rectal cancer.
    Enker WE
    Oncology (Williston Park); 1996 Nov; 10(11):1673-84, 1689; discussion 1690-2. PubMed ID: 8953588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?
    Park IJ; Yu CS; Lim SB; Lee JL; Kim CW; Yoon YS; Park SH; Kim JC
    Medicine (Baltimore); 2016 May; 95(18):e3463. PubMed ID: 27149445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphincter-Preserving Surgery for Low Rectal Cancers: Incidence and Risk Factors for Permanent Stoma.
    Mak JCK; Foo DCC; Wei R; Law WL
    World J Surg; 2017 Nov; 41(11):2912-2922. PubMed ID: 28620675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Nutritional-Inflammatory Index as Predictors for Total Neoadjuvant Therapy-Induced Tumor Regression in Locally Advanced Rectal Cancer Patients.
    Zhao Z; Yan M; Pang H; Chen L; Tang X; Chen Z; Chen X; Sun H
    J Inflamm Res; 2024; 17():3865-3878. PubMed ID: 38895140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factor analysis of low anterior resection syndrome after anal sphincter preserving surgery for rectal carcinoma].
    Liu F; Guo P; Shen Z; Gao Z; Wang S; Ye Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):289-294. PubMed ID: 28338162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer.
    Timudom K; Akaraviputh T; Chinswangwatanakul V; Pongpaibul A; Korpraphong P; Petsuksiri J; Ithimakin S; Trakarnsanga A
    World J Gastrointest Surg; 2020 Sep; 12(9):390-396. PubMed ID: 33024513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument.
    Ihn MH; Kang SB; Kim DW; Oh HK; Lee SY; Hong SM
    Dis Colon Rectum; 2014 Aug; 57(8):958-66. PubMed ID: 25003290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.
    Wolmark N; Fisher B
    Ann Surg; 1986 Oct; 204(4):480-9. PubMed ID: 3532972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?
    Andras D; Crisan D; Craciun R; Nemes A; Caziuc A; Drasovean R; Seicean R; Scurtu R; Bințințan V; Eniu D; Coman I; Dindelegan G
    J BUON; 2020; 25(3):1436-1442. PubMed ID: 32862587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphincter-saving surgery in low rectal cancer.
    Guerriero O; Tufano G; Pennetti L; D'Amore E; Sarnella G; Sodano B
    Chir Ital; 2006; 58(1):83-92. PubMed ID: 16729614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
    Weiser MR; Quah HM; Shia J; Guillem JG; Paty PB; Temple LK; Goodman KA; Minsky BD; Wong WD
    Ann Surg; 2009 Feb; 249(2):236-42. PubMed ID: 19212176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
    Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
    Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.